Navigation Links
OncoGenex Announces Presentation of OGX-427 Data at the ASCO 2012 Genitourinary Cancers Symposium
Date:1/19/2012

ract #286, General Poster Session D - Feb. 3

OncoGenex will host an investigator panel to review the preliminary OGX-427 data and the on-going development program for the compound on Thursday, February 2, 2012 at 6:35 p.m. PT in San Francisco. The panel will include Prof. Joaquim Bellmunt, from the University Hospital del Mar, and Drs. Martin Gleave and Alan So, both from the University of British Columbia.

The event will also be made available via live webcast. To access the event, log on to the Investor Relations page of the OncoGenex website at www.oncogenex.com.  A replay will be made available for approximately 90 days following the event.

About OncoGenex Pharmaceuticals
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new cancer therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. (NASDAQ:  TEVA) have entered a global collaboration and license agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer. The companies plan to begin Phase 3 development of custirsen in first-line treatment of advanced, unresectable non-small cell lung cancer. OGX-427 is in Phase 2 clinical development; CSP-9222 and OGX-225 are currently in pre-clinical development. More information is available at www.OncoGenex.com.

OncoGenex' Forward Looking Statements

This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Priva
'/>"/>

SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. OncoGenex Announces Publication of Phase I/II Custirsen (OGX-011/TV-1011) Data in Journal of Thoracic Oncology
2. OncoGenex Announces Completion of a Special Protocol Assessment (SPA) Amendment with the FDA Increasing Patient Eligibility for the Custirsen Phase III Prostate Cancer SATURN Clinical Trial
3. OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Second Quarter 2011 and Provides Update on Development Activities
4. OncoGenex Announces Data Highlighting OGX-427 at American Association of Cancer Research (AACR) 102nd Annual Meeting 2011
5. OncoGenex Pharmaceuticals to Participate in Panel Discussion on Novel Cancer Treatments at RBC Capital Markets Healthcare Conference
6. Isis Pharmaceuticals to Receive $10 Million From OncoGenex License of OGX-011 to Teva
7. OncoGenex Expands Clinical Development of OGX-427 with a Phase 1 Clinical Trial in Bladder Cancer
8. ShangPharma Announces Milestone Achievement in Research Partnership with Hengrui
9. CME LLC Announces the Launch of the CME Activity Advances in the Management of Major Depressive Disorders
10. Neurocrine Biosciences, Inc. Announces Proposed Public Offering of Common Stock
11. Pharmaceutics International, Inc. (Pii) Announces cGMP Aseptic Facilities Expansion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... , March 4, 2015  NxStage Medical, Inc. (Nasdaq: ... products, today announced that Jeffrey H. Burbank , Chief ... Conference in Miami, FL on Wednesday, ... A webcast of the event will be made available at ... About NxStage NxStage Medical, Inc. (Nasdaq: ...
(Date:3/4/2015)... Acsis Inc., the market leader for supply ... will be hosting a free webinar on supply chain ... Boost Manufacturing Efficiency and Optimize Supply Chain Visibility," will ... EDT.  Presenters John DiPalo , ... , Chief Information Officer for Roosevelt Paper, will be ...
(Date:3/4/2015)... , March 4, 2015  Mail-service and specialty ... consumers, employers and government health plans $11.8 billion ... by the Pharmaceutical Care Management Association (PCMA). ... offers one of the easiest ways to reduce ... Mark Merritt . "Policymakers should resist efforts to ...
Breaking Medicine Technology:NxStage to Present at the Barclays Capital Global Healthcare Conference 2PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Illinois Employers, Consumers and Public Programs by $11.8 Billion 2
(Date:3/4/2015)... 2015 TROY Healthcare Solutions will be ... the ultimate level of security for prescriptions, in Houston, ... Plaza Medical Center located at 6633 Travis Street from ... 7 AM, TROY Healthcare Solutions will host a continental ... offer brief presentations each hour to introduce attendees to ...
(Date:3/4/2015)... NY (PRWEB) March 04, 2015 Smokers ... breakthrough marketing campaign called 'We Love Smokers' from Aqua-Tine, ... for tobacco. , "It’s important to establish a ... true to it. Our idea, 'We Love Smokers' elevates ... point of view. We created a bold tone of ...
(Date:3/4/2015)... Starting February 2015, Dr. Joseph King of King ... new location in Surrey. , In addition to providing ... Chu also provide comprehensive ophthalmology services, including cataract surgery. ... Cataract and Laser (FVCL). This state of the art ... and Surgeons of British Columbia. Fraser Valley Cataract and ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 " Optrix ... part of its monthly Tech Report, which takes a ... services available to consumers. Scott Steinberg, a special reporter ... review and shared with viewers how they have an ... The mobile industry is a major player at the ...
(Date:3/4/2015)... 2015 The New Mel Brooks Musical ... will be performed by the award-winning Drama Department of ... March 6-22, 2015, on Fridays, Saturdays and Sundays. Performances ... School (27118 Silver Spur Road, Rolling Hills Estates, ... program or may be purchased on-line at https://sites.google.com/site/penhidrama ...
Breaking Medicine News(10 mins):Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 2Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 3Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 2Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 3Health News:King LASIK relocates to Surrey, British Columbia 2Health News:A Waterproof Phone Case with an Interchangeable Lens System was Featured on NewsWatch Television on January 30, 2015 2Health News:The New Mel Brooks Musical Young Frankenstein Performance March 6-March 22, 2015, by the Award Winning Drama Department at Peninsula High School, Rolling Hills 2
... raise awareness and advocate for affordable health coverage. Health, ... ... March 3 Leaders from throughout Michigan,including representatives of insurers, health ... of the newly formed,Michigan Cover The Uninsured Network (MCTUN). The goal ...
... and ... care about digestive health, WHITE PLAINS, N.Y., ... campaign for Activia featuring award-winning,actress and passionate self-esteem advocate Jamie ... throughout 2008, Curtis draws attention,to the importance of digestive health, ...
... New portable UV-C Light Sterilizer kills 99 percent of ... Uncomfortable using a public,restroom? Don,t want to touch the ... in the airplane?, (Photo: http://www.newscom.com/cgi-bin/prnh/20080303/CLM086 ), ... from Mark Feldstein & Associates, inc., a,Product Development Company ...
... Boonen of Faculty of 1000 Medicine, researchers look at ... administrative databases used by physicians in Quebec. , ... Rheumatism, report that general practitioners diagnosed 79% of the ... then saw a rheumatologist. Half of these patients were ...
... oil spills, forest fires and car exhaust is also ... way in which smoking delays bone healing, according to ... Orthopaedic Research Society in San Francisco. , In ... identified one ingredient in smoke, nicotine, that delays bone ...
... medicine company,PreMD Inc. (TSX: PMD; Amex: PME) ("PreMD" ... an agreement with Midsummer Investment, Ltd. with,respect to ... existing institutional, qualified investors and insiders have,also agreed ... PreMD will,issue up to CDN $1.22 million of ...
Cached Medicine News:Health News:Michigan Leaders Join Network to Push for Coverage of State's 1.4 Million Uninsured 2Health News:Dannon Activia Launches Thought-Provoking Advertising Campaign Featuring Jamie Lee Curtis 2Health News:Dannon Activia Launches Thought-Provoking Advertising Campaign Featuring Jamie Lee Curtis 3Health News:Live Healthier ... ZAP Those Germs! 2Health News:Toxins in cigarette smoke prevent stem cells from becoming cartilage 2Health News:Toxins in cigarette smoke prevent stem cells from becoming cartilage 3Health News:PreMD Inc. Announces Debenture Financing 2Health News:PreMD Inc. Announces Debenture Financing 3
... Pyrogallol Red Molybdate dye binding method ... for total protein quantitation with greater ... or cerebrospinal fluid (CSF) in manual ... four reagent standards (level 2, 3, ...
SPOT RT KE and RT SE digital camera lines provide maximum performance in a mid-line scientific camera system....
The AutoSet Respond offers ResMeds unique AutoSet algorithm and product quality in a convenient, affordable model. The AutoSet algorithm responds to the patients pressure needs on a breath-by-breath ...
... CPAP System includes the 420E Auto-CPAP model, ... enjoy the advantages of the worlds smallest ... The GoodKnight 420E model records up to ... other features of the 420S model. The ...
Medicine Products: